Description
Detailed description is being prepared by our clinical team.
Clinical Trials
NCT06188520
Phase 1
Recruiting
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
United States, Australia, South Korea, Spain, United Kingdom